Outbreaks of unexplained mortalities attributed to infectious salmon anaemia (ISA) were examined in the 1996 year class of Atlantic salmon in three regions of New Brunswick, Canada. A total of 218 net pens at 14 sites deemed to have been exposed to ISA virus (ISAV) were surveyed for mortality record...

Reference ranges for blood chemical and cellular components in the "healthy" population of interest are required to identify alterations in individuals in association with disease and disorders. The purpose of this study was to determine reference ranges for various constituents of hemolym...

Abstract Infectious salmon anaemia (ISA) virus (ISAV) has been causing disease in New Brunswick since 1996. As a control measure, all fish in an outbreak cage are killed. The objective of this study was to compare ISAV prevalence in cages experiencing an outbreak with healthy cages from the same far...

Over the last 10 years, there have been sporadic increases in early sexual maturation (grilsing) in Atlantic salmon (AS) in seawater grow-out sites in New Brunswick with an apparent upward trend. Grilsing in AS reduces flesh quality and growth. With estimated gross revenue of $250 million in 2002, l...

The first known case of mortality due to infectious salmon anaemia (ISA) virus in Canada occurred in New Brunswick in the late summer of 1996. In an observational study of risk factors associated with ISA virus (ISAV) outbreaks, mortality patterns were used to define cases at the cage level and the ...

Proper monitoring of all stages of sea lice is imperative to ensure the strategic timing of treatments. Although sea lice receive close attention and management for production purposes, there are no regulations for the reporting of lice burdens on salmon farms in Atlantic Canada, nor are there offic...

Reverse transcriptase polymerase chain reaction (RT-PCR), virus isolation (VI) and indirect fluorescent antibody tests (IFAT) are three assays currently used by the salmon industry to identify fish infected with infectious salmon anaemia virus (ISAV). However, no data are available on the repeatabil...

Infectious salmon anaemia (ISA) is an economically important disease in New Brunswick, Canada. Current regulatory control involves detection of ISAv in broodstock, hatcheries and marine sites through a surveillance program. Prior to recent assessments of operating characteristics of diagnostic tests...

A double-blind, randomized control clinical trial was performed to investigate the effectiveness of teflubenzuron in controlling sea lice Lepeophtheirus salmonis on farmed Atlantic salmon Salmo salar. A total of 40 sea cages from 3 commercial cage sites in Atlantic Canada were used in this Good Clin...

A historical control clinical trial was performed to assess the effectiveness of teflubenzuron in controlling sea lice Lepeoptheirus salmonis burdens on farmed Atlantic salmon Salmo salar over time. The study site comprised 9 sea cages, all of which were treated. The teflubenzuron was administered i...

The infectious salmon anemia (ISA) virus causes lethargy, anemia, hemorrhage of the internal organs, and death in farmed Atlantic salmon Salmo salar. It has been a cause of disease in Norwegian farmed Atlantic salmon since 1984 and has since been identified in Canada, Scotland, the United States, an...

Reverse transcriptase-polymerase chain reaction (RT-PCR), virus isolation (VI) and indirect fluorescent antibody test (IFAT) are three tests currently used by the salmon industry to identify fish infected with the infectious salmon anaemia virus (ISAV). However, very limited information is available...

Abstract A randomized, blinded clinical trial was performed to assess the relative effectiveness of five commercial and one experimental vaccine in a population of farmed fish experiencing a bacterial kidney disease (BKD) outbreak that occurred in one study cage that was part of a larger clinical fi...